These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20030653)

  • 41. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maximum intensity projection analysis in magnetic resonance of the breast.
    Carriero A; Di Credico A; Mansour M; Bonomo L
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):77-81. PubMed ID: 12585659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.
    Carriero A; Ambrossini R; Mattei PA; Angelucci D; Bonomo L
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):83-7. PubMed ID: 12585660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An exception to tumour neoangiogenesis in a malignant breast-lesion.
    Baltzer PA; Benndorf M; Gajda M; Kaiser WA
    Breast J; 2010; 16(2):197-8. PubMed ID: 20030653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.
    Knopp MV; Brix G; Junkermann HJ; Sinn HP
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dynamic enhanced MRI and chemosensitivity in breast cancer].
    Nagashima T; Sakakibara M; Miyazaki M; Kazama T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():530-4. PubMed ID: 17682206
    [No Abstract]   [Full Text] [Related]  

  • 49. [Computed tomography laser mammography].
    Bílková A; Janík V; Svoboda B
    Cas Lek Cesk; 2010; 149(2):61-5. PubMed ID: 20662467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenesis in breast cancer: how should we measure this? (Review).
    Pollitt MJ; Hanby AM; Horgan K; Murphy CE; Jones PF; Speirs V
    Oncol Rep; 2005 May; 13(5):931-6. PubMed ID: 15809760
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.